Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California. Show more
Location: 701 Anacapa Street, Santa Barbara, CA, 93101, United States | Website: https://phytanix.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
3.181M
52 Wk Range
$1.46 - $14.28
Previous Close
$1.58
Open
$1.56
Volume
113,950
Day Range
$1.55 - $1.68
Enterprise Value
4.456M
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
11.21%
Institutional Own.
10.11%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
PT00114 Details Major depression, anxiety disorders, PTSD, addiction / substance use disorders | Phase 2 Initiation |
